233 related articles for article (PubMed ID: 19346153)
1. Osteoporosis in Parkinson's disease.
Invernizzi M; Carda S; Viscontini GS; Cisari C
Parkinsonism Relat Disord; 2009 Jun; 15(5):339-46. PubMed ID: 19346153
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis and Parkinson's disease.
Raglione LM; Sorbi S; Nacmias B
Clin Cases Miner Bone Metab; 2011 Sep; 8(3):16-8. PubMed ID: 22461823
[TBL] [Abstract][Full Text] [Related]
3. Assessing Bone Health and Fracture Risk in Parkinson's Disease: Is Bone Mineral Density Enough?
Ganguly J; Bernaola MT
Ann Indian Acad Neurol; 2023; 26(4):361-362. PubMed ID: 37970265
[No Abstract] [Full Text] [Related]
4. Retraction notice to "Risk factors for hip fracture among elderly patients with Parkinson's disease" [Journal of the Neurological Sciences 182 (2001), 89-93].
Sato Y; Kaji M; Tsuru T; Oizumi K
J Neurol Sci; 2024 Jan; 456():122821. PubMed ID: 38087765
[No Abstract] [Full Text] [Related]
5. Osteoporosis in Parkinson's Disease: In Search of the Best Prediction Tool.
Roy A; Naik D
Ann Indian Acad Neurol; 2023; 26(4):359-360. PubMed ID: 37970315
[No Abstract] [Full Text] [Related]
6. Hip fracture outcomes in patients with Parkinson's disease.
Lisk R; Watters H; Yeong K
Clin Med (Lond); 2017 Jun; 17(Suppl 3):s20. PubMed ID: 30958781
[No Abstract] [Full Text] [Related]
7. Parkinson's disease and osteoporosis.
van den Bos F; Speelman AD; Samson M; Munneke M; Bloem BR; Verhaar HJ
Age Ageing; 2013 Mar; 42(2):156-62. PubMed ID: 23132148
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and vitamin D status in Parkinson's disease patients.
van den Bos F; Speelman AD; van Nimwegen M; van der Schouw YT; Backx FJ; Bloem BR; Munneke M; Verhaar HJ
J Neurol; 2013 Mar; 260(3):754-60. PubMed ID: 23052606
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease and the bones.
Gnädinger M; Mellinghoff HU; Kaelin-Lang A
Swiss Med Wkly; 2011; 141():w13154. PubMed ID: 21328097
[TBL] [Abstract][Full Text] [Related]
10. Bone and mineral metabolism in older adults with Parkinson's disease.
Abou-Raya S; Helmii M; Abou-Raya A
Age Ageing; 2009 Nov; 38(6):675-80. PubMed ID: 19684354
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: a meta-analysis.
Zhao Y; Shen L; Ji HF
Bone; 2013 Jan; 52(1):498-505. PubMed ID: 23000281
[TBL] [Abstract][Full Text] [Related]
12. Bone health in Parkinson's disease: a systematic review and meta-analysis.
Torsney KM; Noyce AJ; Doherty KM; Bestwick JP; Dobson R; Lees AJ
J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1159-66. PubMed ID: 24620034
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease and osteoporosis: basic and clinical implications.
Figueroa CA; Rosen CJ
Expert Rev Endocrinol Metab; 2020 May; 15(3):185-193. PubMed ID: 32336178
[No Abstract] [Full Text] [Related]
14. Assessment and management of fracture risk in patients with Parkinson's disease.
Lyell V; Henderson E; Devine M; Gregson C
Age Ageing; 2015 Jan; 44(1):34-41. PubMed ID: 25236847
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease.
Metta V; Sanchez TC; Padmakumar C
Int Rev Neurobiol; 2017; 134():877-890. PubMed ID: 28805587
[TBL] [Abstract][Full Text] [Related]
16. The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease.
Lv L; Tan X; Peng X; Bai R; Xiao Q; Zou T; Tan J; Zhang H; Wang C
Transl Neurodegener; 2020 Sep; 9(1):34. PubMed ID: 32867847
[TBL] [Abstract][Full Text] [Related]
17. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.
Tanner CM; Cummings SR; Schwarzschild MA; Brown EG; Dorsey ER; Espay AJ; Galifianakis NB; Goldman SM; Litvan I; Luthra N; McFarland NR; Mitchell KT; Standaert DG; Bauer DC; Greenspan SL; Beck JC; Lyles KW
NPJ Parkinsons Dis; 2021 Mar; 7(1):16. PubMed ID: 33649343
[TBL] [Abstract][Full Text] [Related]
18. Effects of Neurological Disorders on Bone Health.
Kelly RR; Sidles SJ; LaRue AC
Front Psychol; 2020; 11():612366. PubMed ID: 33424724
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in Parkinson's Disease: Relevance of Distal Radius Dual-Energy X-Ray Absorptiometry (DXA) and Sarcopenia.
Tan YJ; Lim SY; Yong VW; Choo XY; Ng YD; Sugumaran K; Md Shah MN; Raja Aman RRA; Paramasivam SS; Mohd Ramli N; Grossmann M; Tan AH
J Clin Densitom; 2021; 24(3):351-361. PubMed ID: 32888777
[TBL] [Abstract][Full Text] [Related]
20. Bone Mineral Density and Risk of Osteoporotic Fractures in Women with Parkinson's Disease.
Bystrytska M; Povoroznyuk V; Grygorieva N; Karaban I; Karasevich N
J Osteoporos; 2020; 2020():5027973. PubMed ID: 32273970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
